{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:22:31Z","timestamp":1786112551892,"version":"build-2736575974"},"reference-count":92,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Congenital heart disease and common acquired heart diseases like Kawasaki disease and rheumatic heart disease are prevalent cardiovascular conditions in children worldwide. Despite the availability of treatment options, they continue to be significant contributors to morbidity and mortality. Advancements in early diagnosis, improvements in treatment approaches, and overcoming resistance to available treatments are crucial to reduce morbidity. Researchers have turned to precision medicine to tackle these challenges. We aimed to analyze the existing literature concerning the utilization of precision medicine in congenital heart disease, rheumatic heart disease, and Kawasaki disease. The emphasis is placed on comprehending the key themes explored in these studies and evaluating the present state of their clinical integration. The central theme of most studies revolves around the examination of genetic factors. Despite promising research outcomes, limitations in these studies indicate that the clinical implementation of precision medicine in these conditions remains a distant prospect, necessitating additional exploration and attention to confounding factors.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/crd.0000000000000709","type":"journal-article","created":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T09:01:01Z","timestamp":1714640461000},"page":"416-425","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Precision Medicine in Congenital Heart Disease, Rheumatic Heart Disease, and Kawasaki Disease of Children: An Overview of Literature"],"prefix":"10.1097","volume":"34","author":[{"given":"Muhammad Hamza","family":"Khan","sequence":"first","affiliation":[{"name":"From the Department of Internal Medicine, Karachi Medical and Dental College, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Areeba","family":"Ahsan","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Foundation University School of Health Sciences, Islamabad, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fena","family":"Mehta","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Smt. NHL Municipal Medical College, Ahmedabad, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arundati","family":"Kanawala","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Smt. Kashibai Navale Medical College and General Hospital, Pune, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riddhi","family":"Mondal","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Jagannath Gupta Institute of Medical Sciences and Hospital, Kolkata, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aamna","family":"Dilshad","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, International Islamic University, Islamabad, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anum","family":"Akbar","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Nebraska Medical Center, Omaha, NE."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,5,2]]},"reference":[{"key":"R1-20260805","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ahj.2014.11.014","article-title":"Cardiovascular deaths in children: general overview from the National Center for the Review and Prevention of Child deaths.","volume":"169","author":"Vetter","year":"2015","journal-title":"Am Heart J"},{"key":"R2-20260805","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1016\/j.jacc.2011.08.025","article-title":"Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis.","volume":"58","author":"van der Linde","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"R4-20260805","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.21037\/tp-21-297","article-title":"Genetics of congenital heart disease: a narrative review of recent advances and clinical implications.","volume":"10","author":"Yasuhara","year":"2021","journal-title":"Transl Pediatr"},{"key":"R5-20260805","first-page":"192","article-title":"Quality of life and congenital heart disease in childhood and adolescence.","volume":"102","author":"Bertoletti","year":"2014","journal-title":"Arq Bras Cardiol"},{"key":"R6-20260805","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s12013-015-0551-6","article-title":"Congenital heart disease: causes, diagnosis, symptoms, and treatments.","volume":"72","author":"Sun","year":"2015","journal-title":"Cell Biochem Biophys"},{"key":"R7-20260805","first-page":"54","article-title":"Management of congenital heart disease: state of the art; Part I-ACYANOTIC heart defects.","volume":"6","author":"Rao","year":"2019","journal-title":"Children (Basel)"},{"key":"R8-20260805","doi-asserted-by":"crossref","first-page":"609","DOI":"10.4314\/ahs.v14i3.16","article-title":"Childhood acquired heart disease in Nigeria: an echocardiographic study from three centres.","volume":"14","author":"Wilson","year":"2014","journal-title":"Afr Health Sci"},{"key":"R9-20260805","doi-asserted-by":"crossref","first-page":"694393","DOI":"10.3389\/fcvm.2021.694393","article-title":"What Lies Ahead for Young Hearts in the 21(st) Century - Is It Double Trouble of Acute Rheumatic Fever and Kawasaki Disease in Developing Countries?.","volume":"8","author":"Banday","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"R10-20260805","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1056\/NEJMoa1603693","article-title":"Global, regional, and national burden of rheumatic heart disease, 1990-2015.","volume":"377","author":"Watkins","year":"2017","journal-title":"N Engl J Med"},{"key":"R11-20260805","first-page":"100508","article-title":"Risk factors for acute rheumatic fever: a case-control study.","volume":"26","author":"Baker","year":"2022","journal-title":"Lancet Reg Health West Pac"},{"key":"R12-20260805","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1179\/2047773214Y.0000000146","article-title":"Low adherence to secondary prophylaxis among clients diagnosed with rheumatic fever, Jamaica.","volume":"108","author":"Thompson","year":"2014","journal-title":"Pathog Glob Health"},{"key":"R13-20260805","doi-asserted-by":"crossref","first-page":"e43917","DOI":"10.1371\/journal.pone.0043917","article-title":"Socioeconomic and environmental risk factors among rheumatic heart disease patients in Uganda.","volume":"7","author":"Okello","year":"2012","journal-title":"PLoS One"},{"key":"R14-20260805","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3389\/fsurg.2020.00047","article-title":"Clinical profile and management of rheumatic heart disease in children and young adults at a tertiary cardiac center in Indonesia.","volume":"7","author":"Lilyasari","year":"2020","journal-title":"Front Surg"},{"key":"R15-20260805","doi-asserted-by":"crossref","first-page":"e337","DOI":"10.1161\/CIR.0000000000000921","article-title":"Contemporary diagnosis and management of rheumatic heart disease: implications for closing the gap: a scientific statement from the American Heart Association.","volume":"142","author":"Kumar","year":"2020","journal-title":"Circulation"},{"key":"R16-20260805","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1161\/CIR.0000000000000205","article-title":"Revision of the Jones criteria for the diagnosis of acute rheumatic fever in the era of Doppler echocardiography: a scientific statement from the American Heart Association.","volume":"131","author":"Gewitz","year":"2015","journal-title":"Circulation"},{"key":"R17-20260805","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.jacc.2018.06.063","article-title":"Rheumatic heart disease worldwide: JACC scientific expert panel.","volume":"72","author":"Watkins","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"R18-20260805","doi-asserted-by":"crossref","first-page":"305","DOI":"10.21037\/cdt.2019.10.07","article-title":"Rheumatic heart disease: current status of diagnosis and therapy.","volume":"10","author":"Peters","year":"2020","journal-title":"Cardiovasc Diagn Ther"},{"key":"R19-20260805","doi-asserted-by":"crossref","first-page":"1090928","DOI":"10.3389\/fped.2022.1090928","article-title":"Kawasaki disease in Malaysia: biochemical profile, characterization, diagnosis and treatment.","volume":"10","author":"Cheah","year":"2022","journal-title":"Front Pediatr"},{"key":"R20-20260805","doi-asserted-by":"crossref","first-page":"216","DOI":"10.2188\/jea.JE20110126","article-title":"Epidemiologic features of Kawasaki disease in Japan: results of the 2009-2010 nationwide survey.","volume":"22","author":"Nakamura","year":"2012","journal-title":"J Epidemiol"},{"key":"R21-20260805","doi-asserted-by":"crossref","first-page":"g5336","DOI":"10.1136\/bmj.g5336","article-title":"Kawasaki disease.","volume":"349","author":"Harnden","year":"2014","journal-title":"Bmj"},{"key":"R22-20260805","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/01.ede.0000152901.06689.d4","article-title":"Seasonality and temporal clustering of Kawasaki syndrome.","volume":"16","author":"Burns","year":"2005","journal-title":"Epidemiology"},{"key":"R23-20260805","doi-asserted-by":"crossref","first-page":"132","DOI":"10.2188\/jea.JE20190189","article-title":"Seasonal variation in epidemiology of Kawasaki disease-related coronary artery abnormalities in Japan, 1999-2017.","volume":"31","author":"Kitano","year":"2021","journal-title":"J Epidemiol"},{"key":"R24-20260805","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2188\/jea.JE20110131","article-title":"Epidemiology of Kawasaki disease in Asia, Europe, and the United States.","volume":"22","author":"Uehara","year":"2012","journal-title":"J Epidemiol"},{"key":"R25-20260805","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1161\/01.CIR.0000145143.19711.78","article-title":"Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the committee on rheumatic fever, endocarditis and Kawasaki disease, council on cardiovascular disease in the Young, American Heart Association.","volume":"110","author":"Newburger","year":"2004","journal-title":"Circulation"},{"key":"R26-20260805","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/S0022-3476(97)70038-6","article-title":"Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose.","volume":"131","author":"Terai","year":"1997","journal-title":"J Pediatr"},{"key":"R27-20260805","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1136\/heartjnl-2012-302126","article-title":"Intravenous immunoglobulin plus corticosteroid to prevent coronary artery abnormalities in Kawasaki disease: a meta-analysis.","volume":"99","author":"Chen","year":"2013","journal-title":"Heart"},{"key":"R28-20260805","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/s41390-023-02519-z","article-title":"Intravenous immunoglobulin resistance in Kawasaki disease patients: prediction using clinical data.","volume":"95","author":"Lam","year":"2023","journal-title":"Pediatr Res"},{"key":"R29-20260805","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1161\/CIRCRESAHA.117.310782","article-title":"Emerging role of precision medicine in cardiovascular disease.","volume":"122","author":"Leopold","year":"2018","journal-title":"Circ Res"},{"key":"R31-20260805","doi-asserted-by":"crossref","first-page":"e390","DOI":"10.3928\/19382359-20220803-05","article-title":"Precision medicine in pediatric cardiology.","volume":"51","author":"Kikano","year":"2022","journal-title":"Pediatr Ann"},{"key":"R32-20260805","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1016\/j.carpath.2009.06.008","article-title":"Molecular mechanisms of congenital heart disease.","volume":"19","author":"Huang","year":"2010","journal-title":"Cardiovasc Pathol"},{"key":"R33-20260805","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.semcdb.2006.12.003","article-title":"Combinatorial signaling in the heart orchestrates cardiac induction, lineage specification and chamber formation.","volume":"18","author":"Dunwoodie","year":"2007","journal-title":"Semin Cell Dev Biol"},{"key":"R34-20260805","doi-asserted-by":"crossref","first-page":"8780","DOI":"10.1074\/jbc.M208120200","article-title":"Functional analysis of TBX5 missense mutations associated with Holt-Oram syndrome.","volume":"278","author":"Fan","year":"2003","journal-title":"J Biol Chem"},{"key":"R35-20260805","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1086\/323410","article-title":"Novel TFAP2B mutations that cause char syndrome provide a genotype-phenotype correlation.","volume":"69","author":"Zhao","year":"2001","journal-title":"Am J Hum Genet"},{"key":"R36-20260805","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/dvdy.21502","article-title":"Notch2 is required for the proliferation of cardiac neural crest-derived smooth muscle cells.","volume":"237","author":"Varadkar","year":"2008","journal-title":"Dev Dyn"},{"key":"R37-20260805","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/humu.9095","article-title":"DHPLC mutation analysis of Jagged1 (JAG1) reveals six novel mutations in Australian alagille syndrome patients.","volume":"20","author":"Heritage","year":"2002","journal-title":"Hum Mutat"},{"key":"R38-20260805","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1086\/340847","article-title":"PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity.","volume":"70","author":"Tartaglia","year":"2002","journal-title":"Am J Hum Genet"},{"key":"R39-20260805","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1399-0004.2008.01014.x","article-title":"CHD7 mutation spectrum in 28 Swedish patients diagnosed with CHARGE syndrome.","volume":"74","author":"Wincent","year":"2008","journal-title":"Clin Genet"},{"key":"R40-20260805","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1002\/humu.24112","article-title":"Common atrium\/atrioventricular canal defect and postaxial polydactyly: a mild clinical subtype of Ellis-van Creveld syndrome caused by hypomorphic mutations in the EVC gene.","volume":"41","author":"Piceci-Sparascio","year":"2020","journal-title":"Hum Mutat"},{"key":"R41-20260805","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/MOP.0b013e3282f161dc","article-title":"Costello syndrome and related disorders.","volume":"19","author":"Quezada","year":"2007","journal-title":"Curr Opin Pediatr"},{"key":"R42-20260805","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/nature06801","article-title":"The developmental genetics of congenital heart disease.","volume":"451","author":"Bruneau","year":"2008","journal-title":"Nature"},{"key":"R43-20260805","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.pharmthera.2005.03.005","article-title":"Cardiac transcription factor CSX\/NKX2-5: its role in cardiac development and diseases.","volume":"107","author":"Akazawa","year":"2005","journal-title":"Pharmacol Ther"},{"key":"R44-20260805","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3390\/jcdd9060185","article-title":"Epigenetics and congenital heart diseases.","volume":"9","author":"Linglart","year":"2022","journal-title":"J Cardiovasc Dev Dis"},{"key":"R45-20260805","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1080\/15384101.2019.1658476","article-title":"The expanding phenotypes of cohesinopathies: one ring to rule them all!","volume":"18","author":"Pich\u00e9","year":"2019","journal-title":"Cell Cycle"},{"key":"R46-20260805","first-page":"165","article-title":"The role of microRNAs in congenital heart disease.","volume":"30","author":"Nagy","year":"2019","journal-title":"Ejifcc"},{"key":"R47-20260805","first-page":"333","article-title":"MicroRNAs in congenital heart disease.","volume":"3","author":"Smith","year":"2015","journal-title":"Ann Transl Med"},{"key":"R48-20260805","doi-asserted-by":"crossref","first-page":"713","DOI":"10.3390\/cells3030713","article-title":"MicroRNA-421 dysregulation is associated with tetralogy of Fallot.","volume":"3","author":"Bittel","year":"2014","journal-title":"Cells"},{"key":"R49-20260805","doi-asserted-by":"crossref","first-page":"14035","DOI":"10.1073\/pnas.1210730109","article-title":"Genetic and environmental risk factors in congenital heart disease functionally converge in protein networks driving heart development.","volume":"109","author":"Lage","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R50-20260805","doi-asserted-by":"crossref","first-page":"e0130681","DOI":"10.1371\/journal.pone.0130681","article-title":"Prenatal alcohol exposure and congenital heart defects: a meta-analysis.","volume":"10","author":"Yang","year":"2015","journal-title":"PLoS One"},{"key":"R51-20260805","doi-asserted-by":"crossref","first-page":"e38430","DOI":"10.7554\/eLife.38430","article-title":"Thalidomide promotes degradation of SALL4, a transcription factor implicated in Duane radial ray syndrome.","volume":"7","author":"Donovan","year":"2018","journal-title":"Elife"},{"key":"R52-20260805","doi-asserted-by":"crossref","first-page":"a037234","DOI":"10.1101\/cshperspect.a037234","article-title":"Environmental risk factors for congenital heart disease.","volume":"12","author":"Kalisch-Smith","year":"2020","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"R53-20260805","doi-asserted-by":"crossref","first-page":"15084","DOI":"10.1038\/nrdp.2015.84","article-title":"Acute rheumatic fever and rheumatic heart disease.","volume":"2","author":"Carapetis","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"R54-20260805","doi-asserted-by":"crossref","first-page":"611036","DOI":"10.3389\/fmed.2021.611036","article-title":"The genetic control of the rheumatic heart: closing the genotype-phenotype gap.","volume":"8","author":"Abdallah","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"R55-20260805","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1007\/s00296-011-2152-z","article-title":"Understanding rheumatic fever.","volume":"32","author":"Azevedo","year":"2012","journal-title":"Rheumatol Int"},{"key":"R56-20260805","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1001\/jamacardio.2021.1627","article-title":"Association of novel locus with rheumatic heart disease in Black African individuals: findings from the RHDGen study.","volume":"6","author":"Machipisa","year":"2021","journal-title":"JAMA Cardiol"},{"key":"R57-20260805","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3892\/etm.2020.9508","article-title":"Signalling pathways implicated in the pathogenesis of rheumatic heart disease (Review).","volume":"21","author":"Xian","year":"2021","journal-title":"Exp Ther Med"},{"key":"R58-20260805","doi-asserted-by":"crossref","first-page":"104402","DOI":"10.1016\/j.yexmp.2020.104402","article-title":"CD4(+) T cells and TGF\u03b21\/MAPK signal pathway involved in the valvular hyperblastosis and fibrosis in patients with rheumatic heart disease.","volume":"114","author":"Zhao","year":"2020","journal-title":"Exp Mol Pathol"},{"key":"R59-20260805","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1016\/j.ijcard.2013.04.113","article-title":"Focal adhesion kinase mediates atrial fibrosis via the AKT\/S6K signaling pathway in chronic atrial fibrillation patients with rheumatic mitral valve disease.","volume":"168","author":"Zhang","year":"2013","journal-title":"Int J Cardiol"},{"key":"R60-20260805","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000446362","article-title":"Increased \u03b1-Actinin-2 expression in the atrial myocardium of patients with atrial fibrillation related to rheumatic heart disease.","volume":"135","author":"Zhang","year":"2016","journal-title":"Cardiology"},{"key":"R61-20260805","first-page":"4231","article-title":"Snail1 is positively correlated with atrial fibrosis in patients with atrial fibrillation and rheumatic heart disease.","volume":"14","author":"Guo","year":"2017","journal-title":"Exp Ther Med"},{"key":"R62-20260805","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1080\/10520295.2019.1574028","article-title":"Potential involvement of S1PR1\/STAT3 signaling pathway in cardiac valve damage due to rheumatic heart disease.","volume":"94","author":"Wu","year":"2019","journal-title":"Biotech Histochem"},{"key":"R63-20260805","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s11926-014-0423-x","article-title":"Kawasaki disease: pathophysiology, clinical manifestations, and management.","volume":"16","author":"Dimitriades","year":"2014","journal-title":"Curr Rheumatol Rep"},{"key":"R64-20260805","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s11926-020-00941-4","article-title":"Kawasaki disease: an update.","volume":"22","author":"Rife","year":"2020","journal-title":"Curr Rheumatol Rep"},{"key":"R65-20260805","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/ced.14558","article-title":"Kawasaki disease for the paediatric dermatologist: skin manifestations and new insights into the pathophysiology.","volume":"46","author":"Piram","year":"2021","journal-title":"Clin Exp Dermatol"},{"key":"R66-20260805","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/nrmicro1853","article-title":"Searching for the cause of Kawasaki disease--cytoplasmic inclusion bodies provide new insight.","volume":"6","author":"Rowley","year":"2008","journal-title":"Nat Rev Microbiol"},{"key":"R67-20260805","doi-asserted-by":"crossref","first-page":"591","DOI":"10.2217\/fmb-2019-0301","article-title":"Correlation of gut microbial compositions to the development of Kawasaki disease vasculitis in children.","volume":"15","author":"Khan","year":"2020","journal-title":"Future Microbiol"},{"key":"R68-20260805","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s12016-020-08783-9","article-title":"Immunogenetics of Kawasaki disease.","volume":"59","author":"Kumrah","year":"2020","journal-title":"Clin Rev Allergy Immunol"},{"key":"R69-20260805","doi-asserted-by":"crossref","first-page":"e927","DOI":"10.1161\/CIR.0000000000000484","article-title":"Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association.","volume":"135","author":"McCrindle","year":"2017","journal-title":"Circulation"},{"key":"R70-20260805","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ceca.2018.01.002","article-title":"A critical appraisal of the role of intracellular Ca(2+)-signaling pathways in Kawasaki disease.","volume":"71","author":"Bijnens","year":"2018","journal-title":"Cell Calcium"},{"key":"R71-20260805","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/jhg.2008.9","article-title":"Susceptibility genes for Kawasaki disease: toward implementation of personalized medicine.","volume":"54","author":"Hata","year":"2009","journal-title":"J Hum Genet"},{"key":"R72-20260805","doi-asserted-by":"crossref","first-page":"1090056","DOI":"10.3389\/fimmu.2022.1090056","article-title":"The role of FOXO4\/NFAT2 signaling pathway in dysfunction of human coronary endothelial cells and inflammatory infiltration of vasculitis in Kawasaki disease.","volume":"13","author":"Huang","year":"2022","journal-title":"Front Immunol"},{"key":"R73-20260805","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/s41419-019-2021-3","article-title":"Endothelial cell pyroptosis plays an important role in Kawasaki disease via HMGB1\/RAGE\/cathespin B signaling pathway and NLRP3 inflammasome activation.","volume":"10","author":"Jia","year":"2019","journal-title":"Cell Death Dis"},{"key":"R74-20260805","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00431-016-2696-8","article-title":"Genetic variants of ADAM17 are implicated in the pathological process of Kawasaki disease and secondary coronary artery lesions via the TGF-\u03b2\/SMAD3 signaling pathway.","volume":"175","author":"Peng","year":"2016","journal-title":"Eur J Pediatr"},{"key":"R75-20260805","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1001\/jamacardio.2019.5620","article-title":"Prediction of pulmonary to systemic flow ratio in patients with congenital heart disease using deep learning-based analysis of chest radiographs.","volume":"5","author":"Toba","year":"2020","journal-title":"JAMA Cardiol"},{"key":"R76-20260805","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/uog.27503","article-title":"Deep learning model for prenatal congenital heart disease (CHD) screening can be applied to retrospective imaging from the community setting, outperforming initial clinical detection in a well-annotated cohort.","volume":"63","author":"Athalye","year":"2023","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R77-20260805","doi-asserted-by":"crossref","first-page":"e003410","DOI":"10.1161\/CIRCGEN.121.003410","article-title":"Clinical genetic risk variants inform a functional protein interaction network for tetralogy of Fallot.","volume":"14","author":"Reuter","year":"2021","journal-title":"Circ Genom Precis Med"},{"key":"R78-20260805","doi-asserted-by":"crossref","first-page":"103209","DOI":"10.1016\/j.autrev.2022.103209","article-title":"Cytokine imbalance in acute rheumatic fever and rheumatic heart disease: mechanisms and therapeutic implications.","volume":"21","author":"Middleton","year":"2022","journal-title":"Autoimmun Rev"},{"key":"R79-20260805","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s10038-020-0721-2","article-title":"Association of the IL16 Asn1147Lys polymorphism with intravenous immunoglobulin resistance in Kawasaki disease.","volume":"65","author":"Kim","year":"2020","journal-title":"J Hum Genet"},{"key":"R80-20260805","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/s41397-019-0085-1","article-title":"Identification of SAMD9L as a susceptibility locus for intravenous immunoglobulin resistance in Kawasaki disease by genome-wide association analysis.","volume":"20","author":"Kim","year":"2020","journal-title":"Pharmacogenomics J"},{"key":"R81-20260805","doi-asserted-by":"crossref","first-page":"153208","DOI":"10.1016\/j.phymed.2020.153208","article-title":"Adjuvant herbal therapy for targeting susceptibility genes to Kawasaki disease: An overview of epidemiology, pathogenesis, diagnosis and pharmacological treatment of Kawasaki disease.","volume":"70","author":"Tang","year":"2020","journal-title":"Phytomedicine"},{"key":"R82-20260805","first-page":"4","article-title":"Matrix metalloproteinase-9 in pediatric rheumatic heart disease with and without heart failure.","volume":"14","author":"Elhewala","year":"2021","journal-title":"Biomed Rep"},{"key":"R83-20260805","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/archdischild-2017-314512","article-title":"Predictive tool for intravenous immunoglobulin resistance of Kawasaki disease in Beijing.","volume":"104","author":"Yang","year":"2019","journal-title":"Arch Dis Child"},{"key":"R84-20260805","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/S0140-6736(18)32003-8","article-title":"Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a randomised controlled, open-label, blinded-endpoints, phase 3 trial.","volume":"393","author":"Hamada","year":"2019","journal-title":"Lancet"},{"key":"R85-20260805","doi-asserted-by":"crossref","first-page":"bio045633","DOI":"10.1242\/bio.045633","article-title":"Genomic analysis of lncRNA and mRNA profiles in circulating exosomes of patients with rheumatic heart disease.","volume":"8","author":"Luo","year":"2019","journal-title":"Biol Open"},{"key":"R86-20260805","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12969-019-0337-2","article-title":"A low-frequency IL4R locus variant in Japanese patients with intravenous immunoglobulin therapy-unresponsive Kawasaki disease.","volume":"17","author":"Amano","year":"2019","journal-title":"Pediatr Rheumatol Online J"},{"key":"R87-20260805","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1093\/rheumatology\/key356","article-title":"HMGB1 gene polymorphism is associated with coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease.","volume":"58","author":"Ahn","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"R88-20260805","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.4049\/jimmunol.1600388","article-title":"Inositol-triphosphate 3-Kinase C mediates inflammasome activation and treatment response in Kawasaki Disease.","volume":"197","author":"Alphonse","year":"2016","journal-title":"J Immunol"},{"key":"R89-20260805","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.hlc.2014.01.011","article-title":"Elevated hyaluronan levels in patients with rheumatic mitral stenosis and pulmonary arterial thromboembolism.","volume":"23","author":"Kalay","year":"2014","journal-title":"Heart Lung Circ"},{"key":"R90-20260805","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1186\/s13073-014-0102-6","article-title":"Global gene expression profiling identifies new therapeutic targets in acute Kawasaki disease.","volume":"6","author":"Hoang","year":"2014","journal-title":"Genome Med"},{"key":"R91-20260805","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/art.37815","article-title":"Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1\/Th2 cytokine profiles in patients with Kawasaki disease.","volume":"65","author":"Wang","year":"2013","journal-title":"Arthritis Rheum"},{"key":"R92-20260805","first-page":"50","article-title":"speB gene as a specific genetic marker for early detection of rheumatic heart disease in human.","volume":"58","author":"Kaushal","year":"2012","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"R93-20260805","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/S0002-9440(10)63415-3","article-title":"Rheumatic heart disease: proinflammatory cytokines play a role in the progression and maintenance of valvular lesions.","volume":"165","author":"Guilherme","year":"2004","journal-title":"Am J Pathol"},{"key":"R94-20260805","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1161\/01.CIR.99.21.2784","article-title":"HLA class II associations with rheumatic heart disease are more evident and consistent among clinically homogeneous patients.","volume":"99","author":"Gu\u00e9dez","year":"1999","journal-title":"Circulation"}],"container-title":["Cardiology in Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CRD.0000000000000709","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T15:16:00Z","timestamp":1785942960000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/CRD.0000000000000709"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,2]]},"references-count":92,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/crd.0000000000000709","relation":{},"ISSN":["1061-5377","1538-4683"],"issn-type":[{"value":"1061-5377","type":"print"},{"value":"1538-4683","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,2]]}}}